Dynavax Announces Preliminary Unaudited Fourth Quarter and …
Dec 31, 2024 · HEPLISAV-B achieved preliminary quarterly net product revenue of $71 million for the fourth quarter of 2024, an increase of 39% compared to $51 million for the fourth quarter of …
OFF
Dynavax Announces Preliminary Unaudited Fourth Quarter And …
2 weeks from now
Dec 31, 2024 · HEPLISAV-B achieved preliminary quarterly net product revenue of $71 million for the fourth quarter of 2024, an increase of 39% compared to $51 million for the fourth quarter of …
dynavax.com
OFF
Dynavax Announces Preliminary Unaudited Fourth Quarter And …
2 weeks from now
1 day ago · HEPLISAV-B achieved preliminary quarterly net product revenue of $71 million for the fourth quarter of 2024, an increase of 39% compared to $51 million for the fourth quarter of …
prnewswire.com
OFF
Dynavax Announces Preliminary Unaudited Fourth Quarter And …
2 weeks from now
1 day ago · Dynavax Technologies (DVAX) reported preliminary unaudited financial highlights for Q4 and full year 2024.HEPLISAV-B achieved record annual revenue of $268 million, …
stocktitan.net
OFF
Dynavax Technologies Guides Q4 And FY Topline Figures - MSN
2 weeks from now
Dynavax Technologies (NASDAQ:DVAX) expects preliminary 2024 HEPLISAV-B net product revenue grew 26% Y/Y to approximately $268M versus total revenue consensus of $276.94M. …
msn.com
OFF
Dynavax Announces Preliminary Unaudited Fourth Quarter And …
2 weeks from now
Jan 9, 2023 · Preliminary HEPLISAV-B Net Product Revenue for the fourth quarter and full year 2022 were approximately $35 million and $126 million, respectively, representing quarterly and …
prnewswire.com
OFF
Dynavax Sees Q4 HEPLISAV-B Revenue $71M - Markets Insider
2 weeks from now
2 days ago · HEPLISAV-B achieved preliminary quarterly net product revenue of $71M for the fourth quarter of 2024, an increase of 39% compared to $51M for the fourth quarter of 2023. …
businessinsider.com
OFF
DVAX Stock Price Quote | Morningstar
2 weeks from now
6 days ago · Dynavax Announces $100 Million Accelerated Share Repurchase Program. PR Newswire Nov 11, 2024 1:00pm. Dynavax Reports Third Quarter 2024 Financial Results and …
morningstar.com
OFF
Dynavax Announces Preliminary Unaudited Fourth Quarter And …
2 weeks from now
Dec 31, 2024 · HEPLISAV-B achieved preliminary quarterly net product revenue of $71 million for the fourth quarter of 2024, an increase of 39% compared to $51 million for the fourth quarter of …
gurufocus.com
OFF
Dynavax Technologies: Dynavax Announces Preliminary Unaudited …
2 weeks from now
HEPLISAV-B achieved preliminary quarterly net product revenue of $71 million for the fourth quarter of 2024, an increase of 39% compared to $51 million for the fourth quarter of 2023.
finanznachrichten.de
OFF
BioLife Solutions Announces Preliminary Fourth Quarter And Full …
2 weeks from now
1 day ago · Preliminary and unaudited revenue for continuing operations for the fourth quarter of 2024 was $22.7 million, an increase of 31% from $17.4 million for the fourth quarter of 2023.
yahoo.com
OFF
Dynavax (DVAX) Announces Preliminary Unaudited Fourth Quarter …
2 weeks from now
1 day ago · HEPLISAV-B achieved preliminary quarterly net product revenue of $71 million for the fourth quarter of 2024, an increase of 39% compared to $51 million for the fourth quarter of …
streetinsider.com
OFF
Treace Announces Preliminary, Unaudited Fourth Quarter And Full …
2 weeks from now
2 days ago · Preliminary revenue of $68.4 million to $68.8 million in the fourth quarter of 2024, an approximate 10% increase at the midpoint over the same period in 2023. Preliminary revenue …
morningstar.com
OFF
MaxCyte Announces Preliminary Unaudited Fourth Quarter And …
2 weeks from now
1 day ago · Preliminary Unaudited Fourth Quarter and Full Year 2024 Results. Core revenue in the fourth quarter is expected to be between $8.3 million and $8.5 million, compared to $7.2 …
yahoo.com
OFF
Dynavax Announces Preliminary Unaudited Fourth Quarter And …
2 weeks from now
Jan 9, 2023 · Preliminary full year 2022 HEPLISAV-B® vaccine Net Product Revenue of approximately $126 million, representing 104% growth compared to 2021Preliminary full year …
wkbn.com
OFF
PacBio Announces Preliminary Fourth Quarter And Full Year Revenue
2 weeks from now
14 hours ago · Preliminary fourth quarter results: Preliminary, unaudited revenue for the fourth quarter of 2024 is expected to be approximately $39.2 million compared with $58.4 million in …
yahoo.com
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
